Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2019-08-18 Notice of Dividend Amou…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Update - Dividend/Distribution - RMD 4 pages 34.6KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about a dividend payment, including dividend amount, currency, record date, payment date, withholding tax rates, and updates to a previous announcement. It specifically discusses dividend details for holders of Chess Depositary Instruments (CDIs) and includes exchange rate updates. There is no indication that this is a full financial report or earnings release, but rather a formal announcement about dividend payment details. This matches the definition of a 'Notice of Dividend Amount' filing, which announces dividend amounts, payment dates, and related shareholder details.
2019-08-18 English
Form 10K Annual Report 90 pages 1.6MB
Annual Report Classification · 100% confidence The document is titled 'FORM 10-K' and is an 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended June 30, 2019. It includes detailed sections typical of an annual report such as Business, Risk Factors, Legal Proceedings, Management's Discussion and Analysis, Financial Statements, and Executive Compensation. The document is from ResMed Inc. and contains comprehensive financial and operational information. The length is 15,000 characters, indicating a full report rather than a brief announcement. Therefore, this document is classified as an Annual Report (10-K). FY 2019
2019-08-08 English
Appendix 3B 8 pages 431.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number of securities issued, class of securities, issue price, purpose of the issue, and application for quotation of additional securities on the ASX. It references specific ASX rules and includes a quotation agreement. The content is focused on the announcement and details of a new share issue and related securities information, not a financial report or earnings release. The document length is over 11,000 characters, indicating it is a full announcement rather than a brief notice. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues and capital changes.
2019-08-08 English
ResMed Announces Results for the Fourth Quarter of FY2019 12 pages 98.1KB
Interim / Quarterly Report Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 25, 2019, by ResMed Inc. It includes a press release announcing the results of operations for the quarter and fiscal year ended June 30, 2019. The document contains detailed financial results, including revenue, gross margin, net income, earnings per share, and other financial metrics for the quarter and full year. It also discusses operational highlights and dividend declarations. The presence of detailed quarterly and full-year financial data, along with management commentary on results and outlook, indicates this is a comprehensive earnings announcement. The document is not merely a brief earnings release headline but includes substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not a full Annual Report (10-K), nor is it just a short earnings release (ER) as it contains detailed financial tables and discussion. It is not a report publication announcement (RPA) because the full data is included, not just a notice of publication. Hence, the appropriate classification is IR with high confidence. Q4 2019
2019-07-25 English
Dividend/Distribution - RMD 4 pages 33.4KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about a dividend payment, including the dividend amount, ex-date, record date, payment date, currency, withholding tax rate, and other dividend-related details. It does not contain financial statements or comprehensive financial performance data, but rather focuses solely on the announcement of dividend payment specifics. The document length is about 4933 characters, which is sufficient to provide detailed dividend information but not a full financial report. Therefore, this document fits the category of 'Notice of Dividend Amount' (DIV) rather than an Annual Report, Earnings Release, or other financial report types.
2019-07-25 English
Form 8-K 128 pages 343.7KB
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the entry into a material definitive agreement related to the issuance and sale of senior notes (debt financing) by ResMed Inc. It includes detailed terms of the Note Purchase Agreement, the notes issued, covenants, and related financial obligations. This is a clear update on the company's capital structure and financing activities. The document is lengthy (15,000 characters) and contains the full agreement text, not just an announcement or a brief summary. Therefore, it fits the category of Capital/Financing Update (CAP). It is not an annual or quarterly report, audit report, or any other category. Hence, the classification is CAP with high confidence.
2019-07-15 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.